Gjonnaess H, Fagerhol M K, Stormorken H
Br J Obstet Gynaecol. 1975 Feb;82(2):151-7. doi: 10.1111/j.1471-0528.1975.tb02214.x.
Coagulation and fibrinolytic studies were made on 25 women who had a normal puerperium and breast fed their babies and on 32 otherwise healthy women who had lactation suppressed by diethylstilboestrol. In the untreated patients the fibrinogen, Factors VIII and IX, platelet count, and antifibrinolytic activity increased, and the levels of Factors II, VII, and X and of plasminogen and plasminogen proactivator decreased. The incidence of cold activation of Factor VII decreased slowly from the 5th postpartum day onwards. The concentration of antithrombin III which was depressed in pregnancy, increased in the puerperium and was the only observed change that counteracted an increased coagulation potential. Oestrogen treatment produced further increases of Factors II, VII, and X, platelet count, and the cold activation of Factor VII while it decreased the concentration of antithrombin III. These changes favoured coagulation but were possibly to some degree counterbalanced by an increased concentration of plasminogen and decreased antifibrinolytic activity.
对25名产褥期正常且母乳喂养婴儿的女性以及32名其他方面健康但用己烯雌酚抑制泌乳的女性进行了凝血和纤溶研究。在未治疗的患者中,纤维蛋白原、因子VIII和IX、血小板计数及抗纤溶活性增加,而因子II、VII和X以及纤溶酶原和纤溶酶原激活剂水平降低。因子VII冷激活的发生率从产后第5天起缓慢下降。妊娠时降低的抗凝血酶III浓度在产褥期升高,这是唯一观察到的抵消凝血潜能增加的变化。雌激素治疗使因子II、VII和X、血小板计数以及因子VII的冷激活进一步增加,同时降低了抗凝血酶III的浓度。这些变化有利于凝血,但可能在一定程度上被纤溶酶原浓度增加和抗纤溶活性降低所抵消。